Study Examining the Combination of Revlimid (Lenalidomide)and Vidaza (Azacitidine) for Relapsed/Refractory CLL and SLL

Clinical trial NCT01241786 · TERMINATED

Trial details

NCT number: NCT01241786
Sponsor: Hackensack Meridian Health
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia(CLL)Small Lymphocytic Lymphoma

Start date: 2010-07-01
Primary completion: 2011-08-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.